XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 29, 2021
Dec. 30, 2020
Dec. 25, 2019
Cash flows from operating activities:      
Net income (loss) $ 78,073 $ (5,116) $ 117,410
Adjustments to reconcile net income (loss) to cash flows provided by (used in) operating activities:      
Depreciation and amortization 15,446 16,161 19,846
Operating (gains), losses and other charges, net (46,105) 1,808 (91,180)
Gains and amortization on interest rate swap derivatives, net (12,629) (2,164) 0
Amortization of deferred financing costs 1,105 876 608
(Gains) losses on investments 21 (123) (180)
(Gains) losses on early termination of debt and leases (523) 224 (4)
Deferred income tax expense 14,097 3,981 16,005
Decrease of tax valuation allowance (5,031) (3,041) (2,935)
Share-based compensation expense 13,602 7,948 6,694
Changes in assets and liabilities:      
Receivables 1,373 6,378 (2,030)
Inventories (3,879) 101 1,668
Prepaids and other current assets 7,454 (3,872) (4,108)
Other assets (1,881) (1,816) (4,581)
Operating lease assets and liabilities (1,521) 844 (601)
Accounts payable 6,608 (10,682) (5,170)
Accrued payroll 3,113 (2,835) (3,826)
Accrued taxes (317) (774) (2,043)
Other accrued liabilities 12,684 (5,525) (4,144)
Other noncurrent liabilities (5,517) (5,510) 1,898
Net cash flows provided by (used in) operating activities 76,173 (3,137) 43,327
Cash flows from investing activities:      
Capital expenditures (7,355) (6,962) (13,975)
Acquisitions of real estate (10,369) 0 (11,320)
Deposits on real estate acquisitions (3,624) 0 0
Proceeds from sales of real estate and other assets 50,098 9,398 129,721
Investment purchases (500) (1,400) (1,760)
Proceeds from sale of investments 200 2,900 0
Collections on notes receivable 684 1,814 3,654
Issuance of notes receivable (120) (1,099) (1,351)
Net cash flows provided by investing activities 29,014 4,651 104,969
Cash flows from financing activities:      
Revolver borrowings 185,000 140,500 164,400
Revolver payments (225,000) (170,500) (210,900)
Long-term debt payments (2,118) (1,570) (2,464)
Tax withholding on share-based payments (1,516) (4,331) (3,206)
Deferred financing costs (1,853) (1,758) 0
Purchase of treasury stock (29,959) (36,008) (94,459)
Proceeds from issuance of common stock 0 69,571 0
Proceeds from exercise of stock options 116 427 971
Net bank overdrafts (3,125) 2,675 (4,292)
Net cash flows used in financing activities (78,455) (994) (149,950)
Increase (decrease) in cash and cash equivalents 26,732 520 (1,654)
Cash and cash equivalents at beginning of period 3,892 3,372 5,026
Cash and cash equivalents at end of period $ 30,624 $ 3,892 $ 3,372